Miltenyi Biomedicine Gmbh

This study tests a new treatment called MB-CART2019.1 (Zamtocabtagene autoleucel) for people with a fast-growing type of blood cancer called high-risk mantle cell lymphoma. The treatment uses a patient's own immune cells, modified to attack cancer cells, given soon after initial …

This study tests a new way to do stem cell transplants for adults with high-risk blood cancers who don't have a fully matched donor. Doctors will use a special process to remove certain immune cells from the donor's stem cells before transplant, aiming to reduce severe side effec…